IMC Logo.jpg
Immuron Announces Proposed Public Offering of ADSs
July 16, 2019 16:31 ET | Immuron Limited
MELBOURNE, Australia, July 16, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
IMC Logo.jpg
Immuron Prices Underwritten Public Offering of ADSs
May 23, 2019 21:10 ET | Immuron Limited
MELBOURNE, Australia,, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral...
IMC Logo.jpg
Immuron Announces Proposed Public Offering of ADSs
May 23, 2019 16:45 ET | Immuron Limited
MELBOURNE, Australia, May 23, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin...